siRNA screen validation.

Slides:



Advertisements
Similar presentations
Areas How do you work out the area of this shape ? HINT.
Advertisements

Effects of siRNA mediated gene knockdown on the formation of focal adhesions Sabina Winograd-Katz, Zvi Kam and Benjamin Geiger Department of Molecular.
Associative Property of Addition
= 5 = 2 = 4 = 3 How could I make 13 from these shapes? How could I make 19 from these shapes? STARTER.
Effects of MAX reconstitution and of BRG1 depletion in lung cancer cells. Effects of MAX reconstitution and of BRG1 depletion in lung cancer cells. A,
Suppression of ENTPD5 in human NSCLC cells results in decreased AKT activity and decreased proliferation under low-serum conditions. Suppression of ENTPD5.
Nick Macklon, M.D., Ph.D.  Fertility and Sterility 
ETV1 positively regulates KIT expression through direct binding to KIT enhancers in human GIST cells and forms a positive feedback circuit in GIST oncogenesis.
Representation of the evolutionary model.

TIE2hi/VEGFAhi TEMs are present in the TMEM
How Many Colorful Shapes?
 Design and use of a high-throughput screen to identify tumor cell-induced gene activation events in Salmonella.  Design and use of a high-throughput screen.
(A) Schematic representation of the conditional Lats1 locus.
Structure-function models of novel mutants in the PI3K-PTEN-AKT pathway. Structure-function models of novel mutants in the PI3K-PTEN-AKT pathway. A, schematic.
Personalized Medicine: Patient-Predictive Panel Power
Volume 23, Issue 7, Pages (May 2018)
High-throughput combination drug screening to nominate potent drug combinations. High-throughput combination drug screening to nominate potent drug combinations.
Identification of small molecule β‐CATENIN‐TCF antagonists Flow chart outlining the sequential assays leading to the selection of small molecules with.
Vittorio Calzolari et al. JACEP 2017;3:
Network analysis of some transcription factors and chromatin regulators that are directly and positively regulated by OsMADS1. Network analysis of some.
A genome-wide RNAi pooled screen identifies NF1 as a key determinant of RAF inhibitor sensitivity in melanoma cells. A genome-wide RNAi pooled screen identifies.
An siRNA screen identifies BER pathway members as sensitizers to temozolomide (TMZ) in pediatric GBM. A and B, SJG2 and KNS42 cells were transfected with.
Volume 12, Issue 3, Pages (September 2003)
CCL5 and IL-6 promote RAS-driven lung cancer cell proliferation in 3D culture. CCL5 and IL-6 promote RAS-driven lung cancer cell proliferation in 3D culture.
Proposed spiral model for prostate cancer progression.
The role of SRC-C3G-RAP1 signaling in transformation induced by CRKL
Th1 and CTL-based immune signature and elevated checkpoint expression in MSI colorectal cancer. Th1 and CTL-based immune signature and elevated checkpoint.
Shapes.
Translate 5 squares left and 4 squares up.
Optimization of a MYC degradation screen.
Model for the regulation of HIPK2 activity and p53 phosphorylations by the ATM pathway. Model for the regulation of HIPK2 activity and p53 phosphorylations.
Fig. 2. Bacterial/viral score in COCONUT-conormalized whole-blood validation data sets. Bacterial/viral score in COCONUT-conormalized whole-blood validation.
Schematic representation of the therapeutic strategies that can be applied to target ARF876L. Schematic representation of the therapeutic strategies that.
SiRNA screening identifies genes required for the viability of Pim1-ovexpressing prostate cells. siRNA screening identifies genes required for the viability.
Validation of the screen hits.
Association between RB pathway alterations and poor prognosis in early-stage lung adenocarcinoma patients. Association between RB pathway alterations and.
Personalized genomic analyses for cancer mutation discovery and interpretation by Siân Jones, Valsamo Anagnostou, Karli Lytle, Sonya Parpart-Li, Monica.
Sample-wise outlier kinases in ERBB2-positive breast cancer cell lines
Pancreatic cancer cell lines are sensitive to knockdown of outlier kinases. Pancreatic cancer cell lines are sensitive to knockdown of outlier kinases.
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
The truncating mutation c
A schematic representation of NOTCH signaling through DAB1–ABL–TRIO–RHO that stimulates colorectal cancer invasion and metastasis. A schematic representation.
High-throughput siRNA screening results and corresponding patient gene expression data for PP2A subunits. High-throughput siRNA screening results and corresponding.
Master Summaries for Selected Identified Genes.
Association between BRCA1 transcript level and cisplatin sensitivity, BRCA1 promoter methylation, and NtAI. Association between BRCA1 transcript level.
Correlations of the breast cancer hypoxia metagene with Ki67 and the proliferation metagene. Correlations of the breast cancer hypoxia metagene with Ki67.
Mean weight change from original weight of (a) BALB/c (b) DBA/2 mice after one (♦) or two (▴) injections of 10 mg/kg and one (▪) or two (×) injections.
Quantitative PTEN protein expression is associated with pertuzumab sensitivity in vitro and trastuzumab resistance in vivo. Quantitative PTEN protein expression.
Change in FES uptake in the tumor during fulvestrant treatment.
Pros and cons for neoadjuvant immunotherapy.
ROC analysis of MIC-1 and CA19-9.
A, Epigenetic validation results of CBFA2T3 and GABBR2, which were first screened by MSCC sequencing and further confirmed by a Sequenom EpiTYPER assay.
A, Proportion for different in silico predictions at the RNA level.
Trastuzumab resistance siRNA screen identifies PPM1H.
Establishment of HeLa/rtTAA/TRE-N1-IC cell line.
Response to crizotinib in an 8-year-old boy with refractory IMT harboring a TFG–ROS1 fusion. Response to crizotinib in an 8-year-old boy with refractory.
Predicted pathogenic BRCA1 amino acid substitutions are confined to the evolutionarily conserved N- and C-terminal domains. Predicted pathogenic BRCA1.
Germline variants influencing primary tumor type.
G34 H3K36me3 upregulates MYCN which is selectively targetable by kinases that destabilize the protein. G34 H3K36me3 upregulates MYCN which is selectively.
Rapid nucleotide exchange allows irreversible interactions between GDP-bound KRASG12C (middle) and ARS-853 (right). Rapid nucleotide exchange allows irreversible.
Wild-type and oncogenic Ras differentially regulate cell proliferation
PTEN genotype frequently dictates PTEN expression status, but evidence of heterogeneous staining implies polyclonality within some ovarian tumors. PTEN.
In vivo shRNA screening strategy.
Driver pathways and key genes in OSCC
Fig. 1. Schematic description of whole-exome or targeted next-generation sequencing analyses. Schematic description of whole-exome or targeted next-generation.
Schematic representation of the HPV genome, highlighting the regions important in PCR-based HPV analysis. Schematic representation of the HPV genome, highlighting.
Synthetic lethality of ROS1 inhibition in E-cadherin–deficient breast tumor cell lines. Synthetic lethality of ROS1 inhibition in E-cadherin–deficient.
ENTPD5 expression correlates with EGFR and activated AKT levels in human NSCLC. A, percentages of PTEN-low lung adenocarcinoma cases with at least one.
Transcriptome profiling of PD-L1 antibody–treated macrophages showed inflammatory phenotype, increased survival and proliferation, and decreased apoptosis.
Presentation transcript:

siRNA screen validation. siRNA screen validation. A, schematic representation of the screen format. B, screening conditions were optimized using PTEN and p27 siRNA as positive controls. Both PTEN and p27 siRNA cause increased proliferation in the presence of trastuzumab. C, Z-scores of individual siRNA oligonucleotides from human kinases (left) and phosphatases (right). Z-scores above 1.5 (red line, 1.5 standard deviations above the plate mean) were considered hits. p27 (blue triangles) and PTEN (yellow squares) were both in the library and all 4 oligonucleotides targeting each gene are marked on the graph. Si Tuen Lee-Hoeflich et al. Cancer Discovery 2011;1:326-337 ©2011 by American Association for Cancer Research